Altman Michael Seth Insider Trades

Insider Trading History

Track insider trading activity for Altman Michael Seth. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Arya Sciences Acquisition IV
Arya Sciences Acquisition IV ARYD
10% owner, Chief Financial Officer
Holding Value $17.6M 2,647,500 shares
Last Trade
Jul 31, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$3.31M 499,000 shares
$6.64
$6.64
Nautilus Biotechnology
Nautilus Biotechnology NAUT
Director
Holding Value $116k 45,000 shares
Last Trade
Jun 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$115k 45,000 shares
$2.56
$2.58
Lyra Therapeutics
Lyra Therapeutics LYRA
Director
Holding Value $13.2k 30,000 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$465k 30,000 shares
$15.51
$0.44
Lyra Therapeutics
Lyra Therapeutics LYRA
Director
Holding Value $8.8k 20,000 shares
Last Trade
Jun 30, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.11M 20,000 shares
$205.50
$0.44
Nautilus Biotechnology
Nautilus Biotechnology NAUT
Director
Holding Value $116k 45,000 shares
Last Trade
Jun 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$179k 45,000 shares
$3.97
$2.58
Lyra Therapeutics
Lyra Therapeutics LYRA
Director
Holding Value $3.19k 7,250 shares
Last Trade
Jun 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.85M 7,250 shares
$254.50
$0.44
Nautilus Biotechnology
Nautilus Biotechnology NAUT
Director
Holding Value $223k 86,467 shares
Last Trade
Jun 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$233k 86,467 shares
$2.70
$2.58
ARYA Sciences Acquisition V
ARYA Sciences Acquisition V ARYE
10% owner, Chief Financial Officer
Holding Value $5.17M 499,000 shares
Last Trade
Jul 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.99M 499,000 shares
$10.00
$10.36
ARYA Sciences Acquisition V
ARYA Sciences Acquisition V ARYE
10% owner, Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jul 12, 2021 Sale
No data
No data
$10.36
Nautilus Biotechnology
Nautilus Biotechnology NAUT
Director
Holding Value $1.29M 499,000 shares
Last Trade
Jun 09, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
No data
No data
$2.58
Nautilus Biotechnology
Nautilus Biotechnology NAUT
Director
Holding Value $115k 44,435 shares
Last Trade
Jun 09, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$2.58
ARYA Sciences Acquisition III
ARYA Sciences Acquisition III ARYA
10% owner, Chief Financial Officer
Holding Value $496k 44,435 shares
Last Trade
Jun 09, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$496k 44,435 shares
$11.16
$11.16
ARYA Sciences Acquisition III
ARYA Sciences Acquisition III ARYA
10% owner, Chief Financial Officer
Holding Value $40.7M 3,647,500 shares
Last Trade
Jun 09, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$40.7M 3,647,500 shares
$11.16
$11.16
ARYA Sciences Acquisition III
ARYA Sciences Acquisition III ARYA
10% owner, Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jun 09, 2021 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$5.57M 499,000 shares
$11.16
$11.16
Nautilus Biotechnology
Nautilus Biotechnology NAUT
Director
Holding Value $9.41M 3,647,500 shares
Last Trade
Jun 09, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
No data
No data
$2.58
Nautilus Biotechnology
Nautilus Biotechnology NAUT
Director
Holding Value $0 0 shares
Last Trade
Jun 09, 2021 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
No data
No data
$2.58
Nautilus Biotechnology
Nautilus Biotechnology NAUT
Director
Holding Value $0 0 shares
Last Trade
Jun 09, 2021 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
No data
No data
$2.58
Lyra Therapeutics
Lyra Therapeutics LYRA
Director
Holding Value $3.19k 7,250 shares
Last Trade
May 26, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.62M 7,250 shares
$362.00
$0.44
Arya Sciences Acquisition IV
Arya Sciences Acquisition IV ARYD
10% owner, Chief Financial Officer
Holding Value $3.31M 499,000 shares
Last Trade
Mar 02, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.99M 499,000 shares
$10.00
$6.64
Arya Sciences Acquisition IV
Arya Sciences Acquisition IV ARYD
10% owner, Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Feb 25, 2021 Sale
No data
No data
$6.64

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up